Not Yet Recruiting Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients NCT06666998 Conditions Bacteria Infection, Bacterial Resistance to Antimicrobial, Empirical Antimicrobial Therapy, +2 more Locations Not specified View Trial Details
Completed Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets NCT07681544 Conditions Critical Illness, Critically Ill, Disease Attributes, +5 more Locations Hospital Italiano de Buenos Aires — Buenos Aires, Argentina View Trial Details
